Literature DB >> 12188433

Infection in Thai patients with systemic lupus erythematosus: a review of hospitalized patients.

Jeerapat Wongchinsri1, Teerapong Tantawichien, Manathip Osiri, Somchai Akkasilpa, Utis Deesomchok.   

Abstract

Infection is a major cause of morbidity and mortality in patients with systemic lupus erythematosus (SLE). The authors conducted retrospective review of 488 admissions at King Chulalongkorn Memorial Hospital during a 5-year period (1994-1999) to determine the infectious complications in these patients. One hundred ninety-one patients with SL2 were admitted because of infection. Lower respiratory tract infection was the most commonly found in these patients (24.6%) followed by infections of the urinary tract (15.7%), skin (15.7%), septicemia (13.6%) and the musculoskeletal system (11.5%). The most common pathogens were Salmonella spp (12.6%), while Escherichiae coli (9.9%) and Mycobacterium tuberculosis (8.4), respectively.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12188433

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  3 in total

1.  Efficacy of intravenous immunoglobulin treatment in lupus erythematosus chorea.

Authors:  I Lazurova; Z Macejova; K Benhatchi; M Oetterová; E Antolová; R A Asherson; J Rovensky
Journal:  Clin Rheumatol       Date:  2007-05-09       Impact factor: 2.980

Review 2.  SLE and infections.

Authors:  Gisele Zandman-Goddard; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667

3.  A Prospective Study of Cytomegalovirus-Specific Cell-Mediated Immune Monitoring and Cytomegalovirus Infection in Patients With Active Systemic Lupus Erythematosus Receiving Immunosuppressants.

Authors:  Jackrapong Bruminhent; Suphanan Autto; Porpon Rotjanapan; Pintip Ngarmjanyaporn; Asalaysa Bushyakanist; Suppachok Kirdlarp; Pichaya O-Charoen; Chavachol Setthaudom; Prapaporn Pisitkun
Journal:  Open Forum Infect Dis       Date:  2021-05-16       Impact factor: 3.835

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.